Company’s 36-month beta value is 0.77.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for APLM is 0.76M, and currently, short sellers hold a 0.35% ratio of that floaft. The average trading volume of APLM on April 01, 2025 was 11.75K shares.
APLM) stock’s latest price update
The stock price of Apollomics Inc (NASDAQ: APLM) has dropped by -18.53 compared to previous close of 7.61. Despite this, the company has seen a fall of -34.74% in its stock price over the last five trading days. globenewswire.com reported 2025-03-31 that FOSTER CITY, Calif. and TAIPEI, Taiwan, March 31, 2025 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM) (“Apollomics”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, and LaunXP International Co., Ltd., an affiliate of LaunXP Biomedical Co., Ltd. (TWO: 6876) (“LaunXP”), announced today that the parties have entered into an agreement for the development and commercialization in Asia (excluding mainland China, Hong Kong and Macau) (the “LaunXP Territory”) of vebreltinib, Apollomics’ proprietary c-Met inhibitor, in combination with an EGFR inhibitor (“EGFRi”) for the treatment of NSCLC. The EGFRi class of targeted kinase inhibitors is currently a foundational targeted therapy for the treatment of NSCLC and other tumor types.
APLM’s Market Performance
APLM’s stock has fallen by -34.74% in the past week, with a monthly drop of 0.00% and a quarterly drop of -40.90%. The volatility ratio for the week is 19.61% while the volatility levels for the last 30 days are 13.77% for Apollomics Inc The simple moving average for the past 20 days is -21.60% for APLM’s stock, with a -50.71% simple moving average for the past 200 days.
APLM Trading at -21.83% from the 50-Day Moving Average
After a stumble in the market that brought APLM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -91.51% of loss for the given period.
Volatility was left at 13.77%, however, over the last 30 days, the volatility rate increased by 19.61%, as shares sank -6.06% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -34.74% lower at present.
During the last 5 trading sessions, APLM fell by -34.74%, which changed the moving average for the period of 200-days by -72.52% in comparison to the 20-day moving average, which settled at $7.91. In addition, Apollomics Inc saw -36.41% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for APLM
Current profitability levels for the company are sitting at:
- -18.6 for the present operating margin
- 1.0 for the gross margin
The net margin for Apollomics Inc stands at -21.97. The total capital return value is set at -1.78. Equity return is now at value -149.31, with -107.81 for asset returns.
Based on Apollomics Inc (APLM), the company’s capital structure generated 0.18 points at debt to capital in total, while cash flow to debt ratio is standing at -5.69.
Currently, EBITDA for the company is -171.75 million with net debt to EBITDA at 0.55. When we switch over and look at the enterprise to sales, we see a ratio of -6.96. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.25.
Conclusion
In a nutshell, Apollomics Inc (APLM) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
